Overall, the GLP-1 market is expected to experience annual growth exceeding 20% and will hit $133 billion worldwide by 2030, according to a MarketWatch report from February
Run together, they produce a synergistic pulse larger than either alone
Second, early animal studies identified potential signals that warranted further investigation
Butler, F., Alghubayshi, A
Altered daytime fluctuation pattern of plasminogen activator inhibitor 1 in type 2 diabetes patients with coronary artery disease: a strong association with persistently elevated plasma insulin, increased insulin resistance, and abdominal obesity
Sikiri's own lab in 1997 also reported that BPC-157 did something in the brain: it blunted the effects of amphetamine, blocking "the stereotypy produced acutely by amphetamine" [10]